Valiant Laboratories Limited Rights Issue 2025 vs Zodiac Ventures Rights Issue 2025

Comparison between Valiant Laboratories Limited Rights Issue 2025 and Zodiac Ventures Rights Issue 2025.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Valiant Laboratories Limited Rights Issue 2025 and Zodiac Ventures Rights Issue 2025. Valiant Laboratories Limited Rights Issue 2025 is listed on BSE, NSE while Zodiac Ventures Rights Issue 2025 is listed on BSE.

 Valiant Laboratories LimitedZodiac Ventures Ltd
LogoValiant Laboratories Limited Rights Issue 2025 LogoZodiac Ventures Rights Issue 2025 Logo
Listing AtBSE, NSEBSE
Terms of Payment

As per Terms of Payment, The Full amount of the Issue Price, being Rs . 75/- per share, will be payable on Application.

The entire amount of the Issue Price of Rs 6.30 per Rights Equity Share shall be payable at the time of Application.

Entitlement1 Rights Equity Share(s) for every 4 fully paid-up Equity Shares held on Record Date6 Rights Equity Share(s) for every 5 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Valiant Laboratories Limited Rights Issue 2025 rights issue is ₹81.47 Crores, whereas Zodiac Ventures Rights Issue 2025 rights issue size is ₹28.42 Crores.

 Valiant Laboratories LimitedZodiac Ventures Ltd
Issue Size1,08,62,500 shares4,51,08,000 shares
Issue Size (Amount)₹81.47 Crores₹28.42 Crores
Issue Price₹75 per share₹6.3 per share
Face Value₹10 per share₹1 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Valiant Laboratories Limited Rights Issue 2025 is Jul 19, 2025 while record date of Zodiac Ventures Rights Issue 2025 is Jul 18, 2025.

 Valiant Laboratories LimitedZodiac Ventures Ltd
Record DateJul 19, 2025Jul 18, 2025
Credit of Rights EntitlementsJul 21, 2025
Bid/Offer Opens OnJul 28, 2025Jul 31, 2025
Renunciation of Rights EntitlementsAug 05, 2025Aug 08, 2025
Bid/Offer Closes OnAug 08, 2025Aug 25, 2025
Deemed Date of AllotmentAug 11, 2025Sep 03, 2025
Credit DateAug 12, 2025Sep 06, 2025
Listing DateAug 13, 2025Sep 08, 2025

Financials details

Comparison of Valiant Laboratories Limited Rights Issue 2025 and Zodiac Ventures Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Valiant Laboratories LimitedZodiac Ventures Ltd
Financial

Valiant Laboratories Limited Financial Information (Restated Consolidated)

Valiant Laboratories Limited's revenue decreased by 27% and profit after tax (PAT) dropped by 789% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue133.38182.06
Profit After Tax-2.200.32
Net Worth234.31236.86
Reserves and Surplus190.86193.41
Amount in ₹ Crore

Zodiac Ventures Ltd Financial Information (Restated Standalone)

Zodiac Ventures Ltd's revenue increased by 1872% and profit after tax (PAT) rose by 2379% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Assets590.2236.96
Revenue16.420.83
Profit After Tax9.610.39
EBITDA3.541.47
Amount in ₹ Crore

Compare with others

Compare:

Valiant Laboratories Limited Rights Issue 2025 Vs Zodiac Ventures Rights Issue 2025